---
title: Avantor vs Merck KGaA
slug_a: avantor-biorepository-services
slug_b: merck-kgaa
site: cdmo
review_signal_gate: closed
canonical_path: /compare/avantor-biorepository-services/merck-kgaa
---

# Avantor vs Merck KGaA

Side-by-side profile data from each company listing on this directory.

## Avantor

- Profile: [/companies/avantor-biorepository-services](/companies/avantor-biorepository-services)

Avantor — Avantor, operating through VWR distribution and custom manufacturing divisions, supplies mission-critical life science products and services to over 300,000 customer locations globally, with capabilities spanning research, development, and production across 180 countries.

Services: 0. Modalities: 0. Indications: 0. Locations: 30. Certifications: 0. The strongest documented coverage currently appears in locations (30).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.